Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
Neurology. 2011 Apr 19;76(16):1383-8. doi: 10.1212/WNL.0b013e3182167147.
Fibrillar amyloid deposition preferentially affects the frontal lobes, temporal pole/neocortex, and posterior cingulate by age 65 years in APOE ε4 carriers prior to the diagnosis of mild cognitive impairment (MCI) and Alzheimer disease (AD), but is it impairing frontally mediated neuropsychological performance?
A total of 71 ε4 homozygotes (HMZ), 194 ε4 heterozygotes (HTZ), and 356 ε4 noncarriers (NC) who did not differ significantly in mean age (56.6 years), years of education (15.6), gender (70% women), or follow-up duration (6.3 years) had neuropsychological testing every 2 years including the Auditory Verbal Learning Test (AVLT) and frontal/executive tasks sensitive to psychomotor speed, working memory, problem solving, and activity. A subset also received the Iowa Gambling Task (IGT). Findings were then tested in a clinical sample of 27 patients with incident MCI and AD.
APOE ε4 carriers had greater acceleration of decline (quadratic effect) than NC on the AVLT (p = 0.04) but not on any frontal test. APOE ε4 HMZ had greater velocity of decline (linear effects) than NC on all mental arithmetic tests: paced auditory serial attention task (PASAT) 3 second (p = 0.01) and 2 second (p = 0.004) versions; and Wechsler Adult Intelligence Scale-Revised arithmetic (p = 0.048). IGT performance did not differ between 12 ε4 HMZ, 27 ε4 HTZ, and 44 NC. Among 27 patients with incident MCI and AD, the PASAT showed progressive decline preceding diagnosis in 50%.
No frontal cognitive effects were as robust as memory decline. APOE ε4 HMZ declined more quickly than NC on mental arithmetic tests related to frontal lobe-mediated working memory ability.
在轻度认知障碍(MCI)和阿尔茨海默病(AD)诊断之前,APOE ε4 携带者在 65 岁之前,纤维状淀粉样蛋白沉积优先影响额叶、颞极/新皮质和后扣带回,但它是否会损害额叶介导的神经心理学表现?
共有 71 名 ε4 纯合子(HMZ)、194 名 ε4 杂合子(HTZ)和 356 名 ε4 非携带者(NC),他们在平均年龄(56.6 岁)、受教育年限(15.6 年)、性别(70%为女性)和随访时间(6.3 年)方面没有显著差异,他们每 2 年进行一次神经心理学测试,包括听觉词语学习测试(AVLT)和敏感于运动速度、工作记忆、解决问题和活动的额叶/执行任务。一部分人还接受了爱荷华赌博任务(IGT)。然后在 27 名患有首发 MCI 和 AD 的患者的临床样本中对这些发现进行了测试。
APOE ε4 携带者在 AVLT 上的衰退速度(二次效应)比 NC 更快(p=0.04),但在任何额叶测试上都没有。APOE ε4 HMZ 在所有心算测试中的衰退速度(线性效应)都比 NC 更快: paced auditory serial attention task(PASAT)3 秒(p=0.01)和 2 秒(p=0.004)版本;和韦氏成人智力量表修订版算术(p=0.048)。IGT 表现 12 名 ε4 HMZ、27 名 ε4 HTZ 和 44 名 NC 之间没有差异。在 27 名患有首发 MCI 和 AD 的患者中,PASAT 在诊断前表现出进行性下降,占 50%。
没有额叶认知效应像记忆衰退那样明显。APOE ε4 HMZ 在与额叶介导的工作记忆能力相关的心算测试中比 NC 下降得更快。